DRREDDY (DRREDDY) Stock Price, News & Analysis

Name: DRREDDY (DRREDDY) Financial Data & Stock Overview
Creator: Stock Titan
License: https://www.stocktitan.net/terms-of-use

DRREDDY

Company Description

This page collects what Stock Titan holds for DRREDDY, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

Latest News

View All

February 22, 2021

—

Dr. Reddy's Laboratories Announces the Launch of Lansoprazole DR Orally Disintegrating Tablets in the U.S. Market

February 18, 2021

—

Dr. Reddy's Laboratories announces the launch of Fluphenazine Hydrochloride Tablets, USP in the U.S. Market

February 2, 2021

—

Dr. Reddy's Laboratories Announces the Launch of Vigabatrin Tablets, USP in the U.S. Market

January 29, 2021

—

Dr. Reddy’s Q3 & 9M FY21 Financial Results

earnings

January 27, 2021

—

Dr. Reddy’s and GRA announces Avigan Pivotal Studies Update

January 15, 2021

—

Dr. Reddy’s Receives Approval to Conduct Phase 3 Clinical Trial for Sputnik V Vaccine in India

clinical trial

DRREDDY has 9 recent news articles. Key topics include earnings, clinical trial. View all DRREDDY news →

SEC Filings

View All

No SEC filings available for DRREDDY.

Financial Highlights

—

Revenue (latest FY)

—

Net Income (latest FY)

—

Diluted EPS (latest FY)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months